【摘要】 目的探讨卡培他滨联合奥沙利铂治疗晚期结直肠癌的效果。方法选取30例结直肠癌患者,随机分为研究组与对照组,各15例。对照组采用卡培他滨进行治疗,研究组采用卡培他滨联合奥沙利铂进行治疗,分析两组的临床有效率、疾病控制率。结果研究组的有效率为60.0%,高于对照组的40.0%(χ~2=4.87,P<0.05);研究组的疾病控制率高于对照组(χ~2=4.63,P<0.05)。结论卡培他滨联合奥沙利铂治疗晚期结直肠癌临床效果确切。更多还原

【Abstract】 Objective To explore the effect of combination treatment of capecitabine and oxaliplatin on advanced colorectal cancer. Methods Thirty patients with colorectal cancer were randomly divided into the study group and the control group,each with 15 cases. The control group was treated with capecitabine,and the study group was treated with combination treatment of capecitabine and oxaliplatin. The clinical efficiency and disease control rate of the two groups were analyzed. Results The effective rate of the study group was 60.0%,which was higher than that in the control group of 40.0%(χ~2=4.87,P<0.05);the disease control rate of the study group was higher than in the control group(χ~2=4.63,P<0.05). Conclusion The clinical effect of combination treatment of capecitabine and oxaliplatin for advanced colorectal cancer is effective.更多还原